Acevedo-García C, Rosas RA, Rubio ZU, Roque RG, Arias LD

Language: Spanish
References: 9
Page: 182-184
PDF size: 361.14 Kb.

ABSTRACT

Of all malignant neoplasia only 0.2% are prostatic hematologic neoplasia. They can be of primary origin or secondary to hematogenic dissemination of myeloma, lymphoma, or leukemia. Ten percent of non- Hodgkin lymphoma affects the urinary tract but only one percent affects the prostate. It is more frequent in men over sixty years of age. The clinical case is described of a 66-year-old man presenting with 30 kg weight loss, asthenia, hyporexia, nocturia (two interruptions), bladder tenesmus, straining, urinary frequency, dysuria, and decrease in urinary stream flow, all six months prior to consultation.

REFERENCES

1. Weimar G, Culp DA, Loening S. Urogenital involvement by malignant lymphomas. J Urol 1981;125:230-1.

2. Zein TA, Huben R, Lane W, et al. Secondary tumors of the prostate. J Urol 1985;133:615-6.

3. Bonavali SD, Mohandas KM, Iyer R, et al. Non Hodgkins lymphoma of the prostate: a rare site of primary extranodal presentation (report of two cases). Indian J Cancer 1991;28:70-4.

4. Bostwick DG. Iczkowski KA, Amin MB, et al. Malignant lymphoma involving the prostate: report of 62 cases. Cancer 1998;83:732-8.

5. Ferry JA, Young RH. Malignant lymphoma of the genitourinary tract. Pathol Annu 1991;26:227-63.

6. Lewi HJ, White A, Cassidy M, et al. Lymphocytic infiltration of the prostate. Br J Urol 1984;56:301-3.

7. Sarris A, Dimopoulos M, Pugh W, et al. Primary lymphoma of the prostate: good outcome with doxorubicin based combination chemotherapy. J Urol 1995;153:1852-4.

8. Lomas Garcia J, et al. Linfoma B de células grandes primario de próstata. Presentación de un caso. Patología Quirúrgica. Congreso hispanoamericano de Anatomía Patológica, 2009.

9. Walsh P, et al. Campbell: Urología. 8a Ed. Tomo 4. Buenos Aires: Médica Panamericana, 2004.